PDA Webinar: Applying the New June 2020 FDA Guidance on Responding to COVID-19 Infection in Employees in Manufacturing

Online
Ask a Question

Sponsored by Johnson & Johnson

The new FDA guidance provides important information related to performance of risk assessment of the current industry viral control strategies for SARS-CoV-2 virus related to cell culture manufacturing. According to the guidance, this risk assessment may include, but not be limited to the leverage of existing available information on the following:

  • The potential of the SARS-CoV-2 virus to replicate in production cell lines.
  • Whether current cell bank and harvest viral testing would detect SARS-CoV-2.
  • The effectiveness of viral clearance and inactivation steps for SARS-CoV-2.
  • Controls in buffer and media preparation areas.

This and other important areas covered in the guidance will be discussed including, general risk assessment on the manufacturing process when employees are identified as having had COVID-19, the exclusion of potentially infected employees from the workplace, the level of documentation of cleaning and disinfection in non-GMP areas, and the FDA expectation of the response by industry of viral events that may include employees identified as having had COVID-19 infections.

This webinar is intended to provide attendees the opportunity to better understand the expectations outlined in the guidance through a general discussion of the guidance as well as an open Q&A session that has been extended to allow ample time for questions. The panel will consist of both FDA and Industry representatives.

Panelists include:
  • Paul Barone, PhD, Associate Director, Biomanufacturing Research Program at the MIT Center for Biomedical Innovation
  • Tony Cundell, PhD, Principal Consultant, Microbiological Consulting LLC
  • Thomas Kreil, PhD, Vice President Global Head Pathogen Safety, Takeda
  • Alonza Cruse, Director, Office of Pharmaceutical Quality Operations, ORA, U.S. FDA
  • Peter Qiu, PhD, Division Director (Acting), Office of Pharmaceutical Manufacturing Assessment, U.S. FDA
  • Joel Welch, PhD, Associate Director for Biosimilar and Regulatory Policy (Acting), OBP, U.S. FDA

Contact

Program Inquiries
Tel: +1 (301) 656-5900
Exhibition/Sponsorship Inquiries
David Hall
Tel: +1 (240) 688-4405
Training Course Inquiries
Tel: +1 (301) 656-5900
Registration Customer Care
Tel: +1 (301) 656-5900

More information coming soon.

GROUP REGISTRATION DISCOUNT: Register 3 people from the same organization as a group (at the same time) for the event and receive the 4th registration free. Other discounts cannot be applied.

GENERAL TERMS AND CONDITIONS: PDA will send you a confirmation letter within one week of payment being received. You must have this confirmation letter to be considered enrolled in a PDA event. If you have submitted a purchase order or requested an invoice, please be advised that a credit card guarantee is needed. PDA reserves the right to modify the material or speakers/trainers without notice or to cancel an event. If an event is cancelled, registrants will be notified by PDA immediately and will receive a credit (registration fee paid). PDA will not be responsible for any costs incurred by registrants due to cancellation. Please note that the attendee list is shared with attendees, trainers, and exhibitors and may be used to follow up on specific areas of interest after the event. Video, photo, and audio recordings are prohibited at all PDA events.

CANCELLATION: If a cancellation request is received 30 days before the event, a credit (registration fee paid minus a 200.00 USD/EUR processing fee) will be given. No credits will be given for cancellation requests received less than 30 days before the event. Cancellation requests must be emailed to [email protected].

PLEASE READ  PDA is not affiliated or contracted with any outside hotel contracting company. If someone other than PDA or the PDA chosen hotel contacts you suggesting that they represent any PDA event, they do not. It is PDA's recommendation that you book your hotel directly through the official PDA chosen hotel that is listed on our web site.


Online, ,